Kesios Therapeutics
Latest round
- Series A
Last raised
- Dec 2015
Total raised
- $31M
Investors
- 3
About Kesios Therapeutics
Established in 2012, Kesios Therapeutics is based in London, UK and operates as a developer of small molecule drugs for hematological malignancies, such as multiple myeloma and related indications.
Who invested in Kesios Therapeutics
3 investors across 2 rounds
See all investors in Kesios Therapeutics
Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.
Questions about Kesios Therapeutics
Who invested in Kesios Therapeutics?
Kesios Therapeutics has 3 investors on record across 2 venture rounds. Sign up free to see every VC on the cap table and the rounds they joined.
How much funding has Kesios Therapeutics raised?
Kesios Therapeutics has raised 2 venture rounds. Sign up free to see how much each round raised and the total.
When did Kesios Therapeutics last raise money?
Kesios Therapeutics's most recent round on record is a Series A, in Dec 2015.
What does Kesios Therapeutics do?
Established in 2012, Kesios Therapeutics is based in London, UK and operates as a developer of small molecule drugs for hematological malignancies, such as multiple myeloma and related indications.
Where is Kesios Therapeutics headquartered?
Kesios Therapeutics is headquartered in London, UK.
Which VCs invest in companies like Kesios Therapeutics?
Among active investors with capital left to deploy, Index Ventures, Forbion, European Investment Bank and Highland Europe back pharmaceuticals companies at Kesios Therapeutics's stage. Their profiles are linked below.
VCs backing pharmaceuticals startups at Series A
Raising like Kesios Therapeutics? Find the right VCs.
Capital Atlas matches your startup to active investors by stage, sector and region.